Skip to main content
Clinical Trials/NCT07419386
NCT07419386Not yet recruitingNot Applicable

Clinical and Psychosocial Factors Associated With Physical Activity Level in Adults With Marfan Syndrome: A Cross-Sectional Observational Study

University of Oviedo1 site in 1 country118 target enrollmentStarted: February 22, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
118
Locations
1
Primary Endpoint
Measurement of physical activity level

Study Overview

Brief Summary

Background. Marfan syndrome is a genetic connective tissue disorder with cardiovascular and musculoskeletal involvement. Despite clinical advances, many patients exhibit low levels of physical activity, influenced by clinical and psychosocial factors such as fear of exertion, fatigue, or pain. Physical activity behavior in this population remains insufficiently characterized.

Objective. To assess the level of physical activity in adults with Marfan syndrome and to identify the main associated clinical and psychosocial factors, in order to determine predictors of low physical activity.

Methods. An observational, analytical, cross-sectional study will be conducted. Adults with a diagnosis of Marfan syndrome will be included. The primary outcome will be physical activity level, assessed using the International Physical Activity Questionnaire-Short Form. The main independent variables will include kinesiophobia (Tampa Scale for Kinesiophobia), physical activity self-efficacy, perceived fatigue (Fatigue Severity Scale), musculoskeletal pain (Brief Pain Inventory-Short Form), and cardiovascular clinical factors. Potential confounders will include age, sex, body mass index, time since diagnosis, medical recommendations regarding exercise, and current pain. Descriptive analyses and a multivariable logistic regression model will be performed to identify independent predictors of low physical activity.

Expected results. To characterize the level of physical activity in adults with Marfan syndrome and to identify the clinical and psychosocial factors that independently predict low physical activity in this population.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults (≥18 years).
  • A confirmed diagnosis of Marfan syndrome according to accepted clinical criteria used in routine follow-up.
  • Ability to understand and complete an online questionnaire in Spanish.
  • Access to the internet and an appropriate device to complete the survey.
  • Provision of informed consent to participate in the study.

Exclusion Criteria

  • Patients with cognitive impairment or comprehension/literacy difficulties that preclude valid completion of the questionnaires.
  • Who have experienced a major cardiovascular event or undergone recent cardiovascular/aortic surgery that substantially limits physical activity during the most recent reference period (e.g., within the past 3 months).
  • With acute conditions or recent musculoskeletal injuries not attributable to Marfan syndrome that markedly restrict physical activity during the previous 7 days (the reference period of the IPAQ-SF).
  • With incomplete questionnaires for essential variables (IPAQ-SF and/or main predictors)

Arms & Interventions

Observational group

Adults with a diagnosis of Marfan syndrome

Intervention: Adults with Marfan syndrome (Other)

Outcomes

Primary Outcomes

Measurement of physical activity level

Time Frame: Screening visit.

This variable will be assessed using the validated Spanish version of the International Physical Activity Questionnaire-Short Form (IPAQ-SF). The questionnaire records the frequency (days/week) and duration (minutes/day) of vigorous-intensity activities, moderate-intensity activities, and walking performed during the previous 7 days. Total physical activity will be expressed in MET-minutes per week, calculated according to the official IPAQ scoring protocol (8.0 METs for vigorous activity, 4.0 METs for moderate activity, and 3.3 METs for walking). In addition, physical activity level will be categorized as low, moderate, or high, based on the criteria established by the instrument.

Secondary Outcomes

  • Measurement of kinesiophobia (fear of movement or physical exertion)(Screening visit)
  • Measurement of physical activity self-efficacy(Screening visit)
  • Measurement of perceived fatigue(Screening visit)
  • Measurement of musculoskeletal pain(Screening visit)
  • Measurement of history of cardiovascular surgery(Screening visit)
  • Measurement of history of aortic dissection(Screening visit)
  • Measurement of current cardiovascular treatment(Screening visit)
  • Measurement of presence of current or stable aortic pathology(Screening visit)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ruben Cuesta Barriuso

Principal Investigator

University of Oviedo

Study Sites (1)

Loading locations...

Similar Trials